These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8488843)

  • 1. Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.
    van den Maagdenberg AM; Weng W; de Bruijn IH; de Knijff P; Funke H; Smelt AH; Gevers Leuven JA; van't Hooft FM; Assmann G; Hofker MH
    Am J Hum Genet; 1993 May; 52(5):937-46. PubMed ID: 8488843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia.
    Richard P; Beucler I; Pascual De Zulueta M; Biteau N; De Gennes JL; Iron A
    Clin Sci (Lond); 1997 Jul; 93(1):89-95. PubMed ID: 9279208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
    Lohse P; Mann WA; Stein EA; Brewer HB
    J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia.
    Zhao SP; Van den Maagdenberg AM; Vroom TF; Van 't Hooft FM; Gevers Leuvens JA; Havekes LM; Frants RR; Van der Laarse A; Smelt AH
    Clin Sci (Lond); 1994 Mar; 86(3):323-9. PubMed ID: 8156744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.
    Horie Y; Fazio S; Westerlund JR; Weisgraber KH; Rall SC
    J Biol Chem; 1992 Jan; 267(3):1962-8. PubMed ID: 1730728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of denaturing gradient gel electrophoresis to detect DNA sequence differences encoding apolipoprotein E isoforms.
    Parker S; Angelico MC; Laffel L; Krolewski AS
    Genomics; 1993 Apr; 16(1):245-7. PubMed ID: 8486365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
    Smit M; de Knijff P; van der Kooij-Meijs E; Groenendijk C; van den Maagdenberg AM; Gevers Leuven JA; Stalenhoef AF; Stuyt PM; Frants RR; Havekes LM
    J Lipid Res; 1990 Jan; 31(1):45-53. PubMed ID: 2313204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the gene for apolipoprotein E5-Frankfurt (Gln81->Lys, Cys112->Arg) by polymerase chain reaction, restriction isotyping, and temperature gradient gel electrophoresis.
    Ruzicka V; März W; Russ A; Fisher E; Mondorf W; Gross W
    Electrophoresis; 1993 Oct; 14(10):1032-7. PubMed ID: 8125051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.
    Utermann G; Weisgraber KH; Weber W; Mahley RW
    J Lipid Res; 1984 Apr; 25(4):378-82. PubMed ID: 6726088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype.
    Choong ML; Koay ES; Khoo KL; Khaw MC; Sethi SK
    Clin Chem; 1997 Jun; 43(6 Pt 1):916-23. PubMed ID: 9191540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia.
    Hoffmann MM; Scharnagl H; Köster W; Winkler K; Wieland H; März W
    Clin Chim Acta; 2001 Jan; 303(1-2):41-8. PubMed ID: 11163021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects.
    Mailly F; Xu CF; Xhignesse M; Lussier-Cacan S; Talmud PJ; Davignon J; Humphries SE; Nestruck AC
    J Lipid Res; 1991 Apr; 32(4):613-20. PubMed ID: 1713245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.
    Richard P; Thomas G; de Zulueta MP; De Gennes JL; Thomas M; Cassaigne A; Béréziat G; Iron A
    Clin Chem; 1994 Jan; 40(1):24-9. PubMed ID: 8287539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
    Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
    Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).
    Mann WA; Lohse P; Gregg RE; Ronan R; Hoeg JM; Zech LA; Brewer HB
    J Clin Invest; 1995 Aug; 96(2):1100-7. PubMed ID: 7635945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a new variant of apolipoprotein E (apo E-Kochi).
    Suehiro T; Yoshida K; Yamano T; Ohno F
    Jpn J Med; 1990; 29(6):587-94. PubMed ID: 2101409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.